$1,999.00

Quantity: ~1M viable cells
CIRM Line ID: CW50025
Disease: Alzheimer’s Disease
Gender: Female
Sampled age: 68
Ethinicity: Caucasian, not Latino

SKU: EXGS-QNCSVF-CW50025-1M Categories: , , Tag:

Description

Quantity: ~1M viable cells
CIRM Line ID: CW50025
Disease: Alzheimer’s Disease
Gender: Female
Sampled age: 68
Race: Caucasian, not Latino

Donor data

Demographic (source: CIRM) Description ALZHEIMER DISEASE; AD
Affected Status Yes
Product iPSC
Source PBMC
Sex Female
Age at Sampling 68 YR
Race Caucasian
Ethnicity Not Hispanic or Latino
Publications Cited 0
dbGap No
Biopsy Source Blood
Collection Alzheimer’s Disease
Cell Type Stem Cell
Tissue Type Induced pluripotent stem cell
Transformant Episomal
Species sapiens
Common Name human
Detailed Clinical Data false
Clinical data (source: CIRM) AlzheimersDisease AlzheimersDisease
Typical_probable_AD_diagnosis Yes
Age_at_onset_of_dementia 57
Atypical_probable_AD:_Progressive aphasia No
Atypical_probable_AD:_Posterior cortical_atrophy No
APOE_e4_carrier Yes
Amyloid_biomarker_test_conducted_(CSF_or_amyloid_P Yes
Height_(inches) 63
Weight_(pounds) 118
  • Users do not need any additional license for the use of these differentiated cells even when cells are used for high throughput screening or drug discovery.
  • All donor consents include statements on the following:
    • Testing the cells’ DNA (this is referred to as the cell’s genetic code or sequence) and making the information known to other researchers
    • Changing some of the genetic code or sequence within these cells
    • Using cells to test or select drugs to treat disease
    • Transplanting cells or resulting products to humans or animals
      Distributing cells widely (nationally and internationally) for research, training or commercial medical product development
    • Future research and uses unforeseen at this time
  • Donors were screened and negative for HIV, HBV, and HCV. Donors under the age of 18 could opt out of HIV testing; all HCV-positive donors submitted skin punches, not peripheral blood, and were not screened for any infectious agents due to small volume of blood present in punches.
  • Human induced pluripotent stem cells were established by non-integrating episomal reprogramming. Reprogramming and quality control were performed by Cellular Dynamics International.

Characteristics

Please refer this page for some characteristics data.

Documents

Protocol

SDS

Others